Mark Bamforth, MBA

Investing for Successful Advancement of Viral Vector Manufacturing
Wednesday, March 15, 2017
Gene therapies are designed to treat diseases by modifying genetic information, including correcting genes that function improperly or adding normal copies of defective genes. They have the potential to address and ... read more
CDMOs Crucial for Bringing Promising Next-Generation Therapies to Market
Friday, July 29, 2016
More than 500 companies are involved in cell therapy technology,1 while the market for gene therapy is predicted to be valued at greater than $200 billion by 2020.2 Globally, there are over 2300 gene therapy3 and 372 ... read more
Achieving Large-Scale Cell and Gene Therapy Manufacturing
Saturday, April 30, 2016
The cell and gene therapy industry is in the growth phase of its economic life cycle. Significant research and development expenditure by large pharma / biotechs and cell and gene therapy-focused biotechs is driving ... read more

Articles by Mark Bamforth, MBA